Low doses, particularly those of ≤500 ng/kg/min, will cause an initial prehypertensive period characterized by auto potentiation to AngII, and subsequent development of hypertension, depending on the duration of treatment [7,8]. The gene discussed is AGT; the disease is Hypertension.